ArticleJournal of nanobiotechnology2023

LMP2-mRNA lipid nanoparticle sensitizes EBV-related tumors to anti-PD-1 therapy by reversing T cell exhaustion.

Yu Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.